{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:49:47Z","timestamp":1793782187858,"version":"4.6.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.biologicals.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T07:04:44Z","timestamp":1571555084000},"page":"102-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Use of NMR as an analytical tool in the process development of conjugate vaccines against Haemophilus influenzae type b (Hib) and meningococcal serogroup A (MenA)"],"prefix":"10.1016","volume":"62","author":[{"given":"Suresh","family":"Beri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshan","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Ravenscroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2019.10.005_bib1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jpba.2005.01.044","article-title":"NMR assays for carbohydrate-based vaccines","volume":"38","author":"Jones","year":"2005","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.biologicals.2019.10.005_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0065-2318(08)60080-3","article-title":"Biosynthesis of bacterial polysaccharide chains composed of repeating units","volume":"44","author":"Shibaev","year":"1986","journal-title":"Adv Carbohydr Chem Biochem"},{"key":"10.1016\/j.biologicals.2019.10.005_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/biol.2000.0255","article-title":"An NMR spectroscopic identification test for the control of the capsular polysaccharide from Haemophilus influenzae type b","volume":"28","author":"Lemercinier","year":"2000","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2019.10.005_bib4","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0731-7085(02)00462-4","article-title":"Use and validation of NMR assay for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitides used in vaccine manufacture","volume":"30","author":"Jones","year":"2002","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.biologicals.2019.10.005_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/abio.1999.4470","article-title":"Development and validation of an NMR based identity assay for bacterial polysaccharides","volume":"279","author":"Abeygunawadana","year":"2000","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biologicals.2019.10.005_bib6","author":"WHO Technical report series"},{"key":"10.1016\/j.biologicals.2019.10.005_bib7","author":"WHO Technical report series"},{"key":"10.1016\/j.biologicals.2019.10.005_bib8","series-title":"Nuclear magnetic resonance spectroscopy identity testing of bacterial polysaccharides used in vaccine manufacture","year":"2019"},{"key":"10.1016\/j.biologicals.2019.10.005_bib9","series-title":"Process for producing a capsular polysaccharide for use in conjugate vaccine","author":"Hamidi","year":"2009"},{"key":"10.1016\/j.biologicals.2019.10.005_bib10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s10295-008-0428-4","article-title":"Purification of capsular polysaccharide produced by Haemophilus influenzae type b through simple, efficient and suitable for scale-up","volume":"35","author":"Takagi","year":"2008","journal-title":"J Ind Microbiol Biotechnol"},{"key":"10.1016\/j.biologicals.2019.10.005_bib11","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1007\/s12010-012-9750-4","article-title":"Improvement in the purification process of the capsular polysaccharide from Haemophilus influenzae type b by using tangential ultrafiltration and diafiltration","volume":"167","author":"Albani","year":"2012","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.biologicals.2019.10.005_bib12","unstructured":"Ph. Eur. 2.4.24. Identification and control of residual solvents."},{"issue":"6","key":"10.1016\/j.biologicals.2019.10.005_bib13","doi-asserted-by":"crossref","first-page":"E1340","DOI":"10.3390\/molecules23061340","article-title":"Role of O-acetylation in the immunogenicity of bacterial polysaccharide vaccines","volume":"23","author":"Berti","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.biologicals.2019.10.005_bib14","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.vaccine.2008.11.065","article-title":"Frasch. Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa","volume":"27","author":"Lee","year":"2009","journal-title":"Vaccine"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105619301113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105619301113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:13:38Z","timestamp":1760922818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105619301113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":14,"alternative-id":["S1045105619301113"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2019.10.005","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of NMR as an analytical tool in the process development of conjugate vaccines against Haemophilus influenzae type b (Hib) and meningococcal serogroup A (MenA)","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}